Loading...

Kymera Therapeutics, Inc. Peer Comparison

Metric Value Ranking
Market Cap $2.4 Billion 3/12 RVMD
$7.4B
EWTX
$2.4B
KYMR
$2.4B
AGIO
$1.9B
NRIX
$1.3B
GLUE
$416.5M
ELYM
$342.7M
FHTX
$340.9M
CCCC
$224.5M
IPSC
$65.5M
STTK
$63.5M
PRLD
$53.4M
Gross Margin 47% 8/12 NRIX
100%
STTK
100%
PRLD
100%
GLUE
100%
AGIO
91%
FHTX
91%
CCCC
87%
KYMR
47%
RVMD
0%
EWTX
0%
ELYM
0%
IPSC
-100%
Profit Margin -100% 5/12 AGIO
100%
RVMD
0%
EWTX
0%
ELYM
0%
KYMR
-100%
NRIX
-100%
STTK
-100%
CCCC
-100%
FHTX
-100%
PRLD
-100%
GLUE
-100%
IPSC
-100%
EBITDA margin -1928% 11/12 RVMD
-100%
EWTX
-100%
ELYM
-100%
CCCC
-184%
GLUE
-288%
FHTX
-305%
NRIX
-454%
STTK
-598%
PRLD
-1132%
AGIO
-1147%
KYMR
-1928%
IPSC
-3532%
Quarterly Revenue $3.7 Million 6/12 CCCC
$15.4M
NRIX
$13.3M
GLUE
$9.2M
AGIO
$9.0M
FHTX
$7.8M
KYMR
$3.7M
PRLD
$3.0M
STTK
$3.0M
IPSC
$791,000
RVMD
$0
EWTX
$0
ELYM
$0
Quarterly Earnings -$62.5 Million 11/12 AGIO
$947.9M
STTK
-$16.7M
FHTX
-$19.1M
GLUE
-$23.9M
CCCC
-$24.7M
IPSC
-$31.2M
PRLD
-$32.3M
EWTX
-$34.1M
ELYM
-$54.9M
NRIX
-$58.5M
KYMR
-$62.5M
RVMD
-$156.3M
Quarterly Free Cash Flow -$50.0 Million 9/12 ELYM
-$667,000
STTK
-$16.1M
FHTX
-$21.3M
GLUE
-$21.4M
CCCC
-$24.1M
PRLD
-$27.4M
IPSC
-$27.5M
EWTX
-$27.9M
KYMR
-$50.0M
NRIX
-$50.9M
AGIO
-$84.6M
RVMD
-$133.9M
Trailing 4 Quarters Revenue $87.6 Million 1/12 KYMR
$87.6M
NRIX
$54.5M
CCCC
$33.7M
AGIO
$32.9M
FHTX
$25.5M
GLUE
$15.0M
STTK
$6.4M
PRLD
$3.0M
IPSC
$2.7M
RVMD
$0
EWTX
$0
ELYM
$0
Trailing 4 Quarters Earnings -$167.5 Million 10/12 CCCC
$15.4M
NRIX
$13.3M
GLUE
$9.2M
AGIO
$9.0M
FHTX
$7.8M
KYMR
$3.7M
PRLD
$3.0M
STTK
$3.0M
IPSC
$791,000
RVMD
-$0
EWTX
-$0
ELYM
-$0
Quarterly Earnings Growth -18% 8/12 AGIO
1138%
STTK
39%
GLUE
32%
CCCC
31%
RVMD
9%
IPSC
5%
PRLD
2%
KYMR
-18%
FHTX
-33%
EWTX
-33%
NRIX
-40%
ELYM
-952%
Annual Earnings Growth 1% 8/12 AGIO
297%
CCCC
23%
STTK
18%
GLUE
15%
FHTX
11%
ELYM
6%
IPSC
2%
KYMR
1%
PRLD
-7%
RVMD
-16%
NRIX
-27%
EWTX
-38%
Quarterly Revenue Growth -21% 10/12 IPSC
434%
STTK
337%
AGIO
21%
CCCC
0%
PRLD
0%
EWTX
0%
GLUE
0%
ELYM
0%
NRIX
-12%
KYMR
-21%
FHTX
-55%
RVMD
-100%
Annual Revenue Growth 61% 4/12 IPSC
503%
STTK
400%
CCCC
199%
KYMR
61%
AGIO
19%
PRLD
0%
EWTX
0%
GLUE
0%
ELYM
0%
NRIX
-23%
FHTX
-26%
RVMD
-100%
Cash On Hand $110.7 Million 5/12 AGIO
$253.7M
ELYM
$223.1M
RVMD
$201.3M
GLUE
$125.6M
KYMR
$110.7M
NRIX
$110.0M
CCCC
$59.6M
FHTX
$57.7M
IPSC
$52.6M
EWTX
$44.8M
STTK
$43.8M
PRLD
$11.1M
Short Term Debt $12.9 Million 2/12 AGIO
$16.3M
KYMR
$12.9M
FHTX
$8.8M
RVMD
$8.4M
NRIX
$8.0M
CCCC
$5.6M
PRLD
$5.4M
IPSC
$3.8M
GLUE
$3.6M
EWTX
$992,000
ELYM
$100,000
STTK
-$0
Long Term Debt $75.4 Million 3/12 IPSC
$101.7M
RVMD
$78.3M
KYMR
$75.4M
CCCC
$61.5M
AGIO
$44.5M
GLUE
$40.1M
FHTX
$30.3M
NRIX
$20.3M
PRLD
$15.4M
EWTX
$3.4M
STTK
$2.7M
ELYM
$0
PE -1.00 2/12 AGIO
2.82
KYMR
-1.00
RVMD
-1.00
NRIX
-1.00
STTK
-1.00
CCCC
-1.00
FHTX
-1.00
PRLD
-1.00
EWTX
-1.00
GLUE
-1.00
ELYM
-1.00
IPSC
-1.00
PS 27.28 3/12 AGIO
57.90
GLUE
27.82
KYMR
27.28
NRIX
24.47
IPSC
24.38
PRLD
17.79
FHTX
13.36
STTK
9.87
CCCC
6.67
RVMD
-1.00
EWTX
-1.00
ELYM
-1.00
PB 2.67 3/12 EWTX
4.92
RVMD
4.73
KYMR
2.67
NRIX
2.53
GLUE
2.03
ELYM
1.54
AGIO
1.17
CCCC
0.93
STTK
0.66
PRLD
0.34
IPSC
0.33
FHTX
0.00
PC 21.57 3/12 EWTX
53.66
RVMD
36.85
KYMR
21.57
NRIX
12.14
AGIO
7.50
FHTX
5.91
PRLD
4.79
CCCC
3.76
GLUE
3.32
ELYM
1.54
STTK
1.45
IPSC
1.24
Liabilities to Equity 0.16 6/12 IPSC
0.99
CCCC
0.55
GLUE
0.53
NRIX
0.27
PRLD
0.26
KYMR
0.16
STTK
0.16
RVMD
0.13
AGIO
0.10
EWTX
0.05
ELYM
0.02
FHTX
0.00
ROA -0.16 2/12 AGIO
38%
KYMR
-16%
EWTX
-24%
CCCC
-28%
ELYM
-28%
NRIX
-29%
FHTX
-30%
RVMD
-31%
IPSC
-33%
GLUE
-38%
STTK
-67%
PRLD
-68%
ROE -0.19 3/12 FHTX
322%
AGIO
41%
KYMR
-19%
EWTX
-25%
ELYM
-29%
RVMD
-34%
NRIX
-37%
CCCC
-43%
GLUE
-58%
IPSC
-66%
STTK
-78%
PRLD
-85%
Current Ratio 7.29 6/12 ELYM
60.42
EWTX
22.82
AGIO
10.85
RVMD
8.96
STTK
7.38
KYMR
7.29
PRLD
4.84
NRIX
4.70
GLUE
2.87
CCCC
2.82
IPSC
2.01
FHTX
0.92
Quick Ratio 3.88 6/12 AGIO
2.82
KYMR
-1.00
RVMD
-1.00
NRIX
-1.00
STTK
-1.00
CCCC
-1.00
FHTX
-1.00
PRLD
-1.00
EWTX
-1.00
GLUE
-1.00
ELYM
-1.00
IPSC
-1.00
Long Term Debt to Equity 0.08 5/12 IPSC}
0.52
CCCC}
0.25
GLUE}
0.19
PRLD}
0.10
KYMR}
0.08
RVMD}
0.05
NRIX}
0.04
AGIO}
0.03
STTK}
0.03
EWTX}
0.01
ELYM}
0.00
FHTX}
-1.07
Debt to Equity 0.10 5/12 CCCC
0.28
IPSC
0.26
GLUE
0.21
PRLD
0.12
KYMR
0.10
RVMD
0.06
NRIX
0.05
AGIO
0.04
STTK
0.03
EWTX
0.01
ELYM
0.00
FHTX
-1.38
Burn Rate 1.61 7/12 GLUE
4.76
ELYM
4.06
STTK
2.61
FHTX
2.56
CCCC
2.09
NRIX
1.79
KYMR
1.61
IPSC
1.45
EWTX
1.30
RVMD
1.25
PRLD
0.33
AGIO
-0.27
Cash to Cap 0.05 10/12 IPSC
0.80
STTK
0.69
ELYM
0.65
GLUE
0.30
CCCC
0.27
PRLD
0.21
FHTX
0.17
AGIO
0.13
NRIX
0.08
KYMR
0.05
RVMD
0.03
EWTX
0.02
CCR 0.80 10/12 FHTX
1.11
CCCC
0.98
STTK
0.97
GLUE
0.90
IPSC
0.88
NRIX
0.87
RVMD
0.86
PRLD
0.85
EWTX
0.82
KYMR
0.80
ELYM
0.01
AGIO
-0.09
EV to EBITDA -32.81 12/12 RVMD}
-1.00
EWTX}
-1.00
ELYM}
-1.00
STTK}
-1.25
PRLD}
-1.78
IPSC}
-2.28
CCCC}
-8.21
GLUE}
-12.62
FHTX}
-13.51
AGIO}
-16.64
NRIX}
-20.76
KYMR}
-32.81
EV to Revenue 27.02 2/12 AGIO
52.04
KYMR
27.02
IPSC
23.73
NRIX
22.97
GLUE
22.35
PRLD
20.13
FHTX
12.63
CCCC
6.89
STTK
3.48
RVMD
-1.00
EWTX
-1.00
ELYM
-1.00